News

Filter

Current filters:

DermatologicalsDiane-35

Benefits of Diane 35 and generics outweigh risks in specific patient group, says EMA unit; other actions

17-05-2013

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has concluded that…

almitrineAnti-Arthritics/RheumaticsBayerDermatologicalsDiane-35EuropeOsseorPharmaceuticalProtelosRegulation

French medicines regulator takes Bayer acne drug Diane-35 off market

01-02-2013

Following a recent investigation (The Pharma Letter January 29), the French medicines agency (ANSM) announced…

BayerDermatologicalsDiane-35EuropePharmaceuticalReproductiveWomen's Health

EMA to review third- and fourth-generation combined OCs; France investigates Diane-35

29-01-2013

The European Medicines Agency has been asked by France to review third- and fourth-generation combined…

BayerDermatologicalsDiane-35EuropePharmaceuticalRegulationReproductiveWomen's Health

COMPANY SPOTLIGHT

Menarini

Back to top